ArticleRegenerative biomaterials2022

Cytarabine delivered by CD44 and bone targeting redox-sensitive liposomes for treatment of acute myelogenous leukemia.

Hao Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.